MoneyWorks4Me

The sales slipped to Rs. 132.98 millions for the March 2025 quarter as against Rs. 147.22 millions during the year-ago period.A slender decline of -9.16% was recorded to Rs. 10.41  millions from Rs. 11.46 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 28.05 millions from 29.49 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 132.98 147.22 -9.67 559.79 558.83 0.17 559.79 558.83 0.17
Other Income -1.95 4.20 -146.43 1.76 3.75 -53.07 1.76 3.75 -53.07
PBIDT 28.05 29.49 -4.88 91.40 83.22 9.83 91.40 83.22 9.83
Interest 4.77 5.30 -10.00 20.66 21.49 -3.86 20.66 21.49 -3.86
PBDT 23.28 24.19 -3.76 70.74 61.73 14.60 70.74 61.73 14.60
Depreciation 9.06 8.91 1.68 35.60 35.65 -0.14 35.60 35.65 -0.14
PBT 14.22 15.28 -6.94 35.14 26.08 34.74 35.14 26.08 34.74
TAX 3.81 3.82 -0.26 9.04 6.52 38.65 9.04 6.52 38.65
Deferred Tax -5.33 0.61 -973.77 -4.55 1.99 -328.64 -4.55 1.99 -328.64
PAT 10.41 11.46 -9.16 26.10 19.56 33.44 26.10 19.56 33.44
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 21.09 20.03 5.30 16.33 14.89 9.64 16.33 14.89 9.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..